Beta Drugs Limited — Important, 22-11-2024: Updates

A board meeting has been scheduled to approve the allotment of 100 fully paid-up equity shares at ₹1,653.40 each, along with 7,07,651 fully paid-up unsecured compulsory convertible debentures (CCDs) at the same price, as part of a preferential issue previously authorized by shareholders. Additionally, the board will consider adopting the restated Articles of Association, pending shareholder approval. The outcomes of this meeting could affect shareholder stake and governance, so it's a development worth monitoring closely.